142 related articles for article (PubMed ID: 36788074)
21. HER2-positive mucinous adenocarcinomas of the ovary have an expansile invasive pattern associated with a favorable prognosis.
Kim SK; Cho NH
Int J Clin Exp Pathol; 2014; 7(7):4222-30. PubMed ID: 25120802
[TBL] [Abstract][Full Text] [Related]
22. Mucinous tumors of the ovary: interobserver diagnostic variability and utility of sectioning protocols.
Raab SS; Robinson RA; Jensen CS; Ozkutlu D; O'Reilly PO; Savell VH; Thomas PA
Arch Pathol Lab Med; 1997 Nov; 121(11):1192-8. PubMed ID: 9372748
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of 103 ovarian serous and mucinous tumors.
Vereczkey I; Serester O; Dobos J; Gallai M; Szakács O; Szentirmay Z; Tóth E
Pathol Oncol Res; 2011 Sep; 17(3):551-9. PubMed ID: 21136228
[TBL] [Abstract][Full Text] [Related]
24. Mucinous tumors of the ovary: current thoughts on diagnosis and management.
Brown J; Frumovitz M
Curr Oncol Rep; 2014 Jun; 16(6):389. PubMed ID: 24777667
[TBL] [Abstract][Full Text] [Related]
25. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
Li XS; Sun J; He XL
Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
[TBL] [Abstract][Full Text] [Related]
26. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.
Prat J; D'Angelo E; Espinosa I
Hum Pathol; 2018 Oct; 80():11-27. PubMed ID: 29944973
[TBL] [Abstract][Full Text] [Related]
27. Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.
Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Oncologist; 2018 Mar; 23(3):324-327. PubMed ID: 29242280
[TBL] [Abstract][Full Text] [Related]
28. The pathologic distinction of primary and metastatic mucinous tumors involving the ovary: A re-evaluation of algorithms based on gross features.
Hu J; Khalifa RD; Roma AA; Fadare O
Ann Diagn Pathol; 2018 Dec; 37():1-6. PubMed ID: 30179792
[TBL] [Abstract][Full Text] [Related]
29. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
Tabrizi AD; Kalloger SE; Köbel M; Cipollone J; Roskelley CD; Mehl E; Gilks CB
Int J Gynecol Pathol; 2010 Mar; 29(2):99-107. PubMed ID: 20173494
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience.
Hashmi AA; Naz S; Edhi MM; Faridi N; Hussain SD; Mumtaz S; Khan M
World J Surg Oncol; 2016 Mar; 14():91. PubMed ID: 27029917
[TBL] [Abstract][Full Text] [Related]
31. Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature.
Ludwick C; Gilks CB; Miller D; Yaziji H; Clement PB
Int J Gynecol Pathol; 2005 Jul; 24(3):205-17. PubMed ID: 15968194
[TBL] [Abstract][Full Text] [Related]
32. Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms.
Lee YJ; Lee MY; Ruan A; Chen CK; Liu HP; Wang CJ; Chao WR; Han CP
Oncotarget; 2016 Dec; 7(50):82097-82103. PubMed ID: 27888800
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological Characteristics of Ovarian Metastasis from Colorectal and Pancreatobiliary Carcinomas Mimicking Primary Ovarian Mucinous Tumor.
Park CK; Kim HS
Anticancer Res; 2018 Sep; 38(9):5465-5473. PubMed ID: 30194204
[TBL] [Abstract][Full Text] [Related]
34. KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation Sequencing.
Matson DR; Xu J; Huffman L; Barroilhet L; Accola M; Rehrauer WM; Weisman P
Am J Case Rep; 2017 May; 18():558-562. PubMed ID: 28526814
[TBL] [Abstract][Full Text] [Related]
35. Two types of primary mucinous ovarian tumors can be distinguished based on their origin.
Simons M; Simmer F; Bulten J; Ligtenberg MJ; Hollema H; van Vliet S; de Voer RM; Kamping EJ; van Essen DF; Ylstra B; Schwartz LE; Wang Y; Massuger LF; Nagtegaal ID; Kurman RJ
Mod Pathol; 2020 Apr; 33(4):722-733. PubMed ID: 31695154
[TBL] [Abstract][Full Text] [Related]
36. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
[TBL] [Abstract][Full Text] [Related]
37. Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations.
Hunter SM; Gorringe KL; Christie M; Rowley SM; Bowtell DD; ; Campbell IG
Clin Cancer Res; 2012 Oct; 18(19):5267-77. PubMed ID: 22891197
[TBL] [Abstract][Full Text] [Related]
38. Is stromal microinvasion in primary mucinous ovarian tumors with "mucin granuloma" true invasion?
Kim KR; Lee HI; Lee SK; Ro JY; Robboy SJ
Am J Surg Pathol; 2007 Apr; 31(4):546-54. PubMed ID: 17414101
[TBL] [Abstract][Full Text] [Related]
39. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
[TBL] [Abstract][Full Text] [Related]
40. MRI in differentiating ovarian borderline from benign mucinous cystadenoma: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Wang SJ; Qiu HY; Wang L
J Magn Reson Imaging; 2014 Jan; 39(1):162-6. PubMed ID: 24123278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
